Reading the annual reports…
First time this company is opened: we are analysing its official reports. This can take up to a minute; after that the page loads instantly.
First time this company is opened: we are analysing its official reports. This can take up to a minute; after that the page loads instantly.
WULF · Nasdaq · United States · Finance Services
In shortTERAWULF INC. is loss-making.
Financial health
Weak
Built from five areas over the last five annual reports. Tap an area to see the figures behind it. Bank or insurer: tests that do not apply to them are left out.
| Operating marginShare of each sale left after running the business, before interest and tax. | -110.5% | 0/100 |
|---|---|---|
| Net marginShare of each sale left as profit after every cost, interest and tax. | -392.6% | 0/100 |
| Return on equityProfit earned on the money shareholders put in. Above 15% is strong. | -343.7% | 0/100 |
Weight in the score: 25%
| Free cash flow marginCash left from each sale after investments. The money that can pay dividends or reduce debt. | -702.5% | n/a |
|---|---|---|
| Free cash flow / net incomeHow much accounting profit turns into real cash. Near 1 or above is healthy. | – | n/a |
| Years with positive free cash flow (last 5) | 0 of 5 | n/a |
Weight in the score: 20%
| Profitable years (last 5) | 0 of 5 | 0/100 |
|---|---|---|
| Years of revenue decline (last 5) | 1 of 5 | 67/100 |
| Revenue growth volatility | 155.8% | 0/100 |
| Operating margin volatility | 111.2% | 0/100 |
Weight in the score: 20%
| Revenue growth, 3-year average | 123.8% | 100/100 |
|---|---|---|
| EPS growth, 3-year average | – | n/a |
Weight in the score: 10%
Fiscal year 2025 · change vs prior year
Annual figures as reported. Hover a bar or point for the exact value.
5 older years available with the 10-year history. Essential plan, from €8.25/month →
The last 5 fiscal years from the company's annual reports.
USD millions; negative values in parentheses.
| Fiscal year | FY20 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|
| Revenue | 13 | 15 | 69 | 140 | 168 |
| Cost of revenue | 9.5 | 11 | 27 | 63 | 83 |
| Gross profit | 3.9 | 4 | 37 | 70 | 66 |
| Research & development | 0.7 | – | – | – | – |
| Selling, general & admin | 5 | 23 | – | – | – |
| Operating income | (1.8) | (44) | (29) | (76) | (186) |
| Interest expense | 0.1 | 25 | 35 | 20 | 80 |
| Pre-tax income | (0.6) | (86) | (73) | (72) | (661) |
| Income tax | (0.2) | (0.3) | 0 | 0 | 0.1 |
| Net income | (0.4) | (91) | (73) | (72) | (661) |
| Diluted EPS | −$0.22 | −$0.82 | −$0.35 | −$0.21 | −$1.66 |
| Diluted shares (millions) | 2 | 111 | 210 | 351 | 398 |
5 older years available with the 10-year history. Essential plan, from €8.25/month →
Not computed: the model does not apply to banks and insurers.
1/9
Nine yes-or-no tests on profitability, debt, liquidity and efficiency versus the prior year. 7 to 9 is strong, 0 to 3 is weak.
All figures: SEC EDGAR. Ratios and scores are computed by Scorvest (see how it works). Information only, not investment advice. How it works
Latest annual report: Jun 30, 2026 · Data updated Aug 5, 2026